Newsletter Subject

Methotrexate Tied to Greater Risks for Older Patients With CKD

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Nov 28, 2023 11:50 PM

Email Preheader Text

Daily Headlines Tuesday, November 28, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIG

[MEDPAGE TODAY]( Daily Headlines Tuesday, November 28, 2023 Today's Top Stories for {NAME} [NEPHROLOGY]( [Methotrexate Tied to Greater Risks for Older Patients With CKD]( [NEUROLOGY]( [FDA Warns of Rare Life-Threatening Reaction to Anti-Seizure Drugs]( [OB/GYN]( [Texas Abortion Case Spotlights Issues Around Medical Exceptions to Abortion Bans]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Evidence-Based Management of Adverse Effects of Immunotherapy in Relapsed/Refractory Multiple Myeloma]( [POP MEDICINE]( [Stephen Colbert Has Surgery for Ruptured Appendix]( [SPECIAL REPORTS]( [Medical Staff Credentialing Case Heads to New Jersey Supreme Court]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer]( CME SPOTLIGHT [Employing Collaborative Care Strategies for the Management of Pediatric Patients With Hodgkin Lymphoma]( [ONCOLOGY/HEMATOLOGY]( [FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy]( [MEETING COVERAGE]( [Simplified Assessment Tool for Psoriatic Arthritis Performs Well]( [NEUROLOGY]( [Alzheimer's Tied to Military Service; Long COVID Sleepiness; NurOwn Tries Again]( CME SPOTLIGHT [Uncovering the Under-Diagnosed in MDS: The MDS Diagnostic Accelerator Hub]( [EMERGENCY MEDICINE]( [Discharge Against Medical Advice More Likely for Black Patients at the ED]( [OB/GYN]( [Mailing HPV Self-Sampling Kits to Patients Boosted Cervical Cancer Screening]( [MEETING COVERAGE]( [Biologic Therapy for IBD Not Tied to Higher Risk of Major Heart Events]( CME SPOTLIGHT [Uncovering the Burden of Anemia in Patients With Myelodysplastic Syndrome, Myelofibrosis, and Beta Thalassemia]( [ONCOLOGY/HEMATOLOGY]( [FDA Approves First Therapy for Progressive Desmoid Tumors]( [OPINION]( [Ask Your Patients: 'Have You Gotten Your Annual COVID Shot?']( [OPINION]( [For Better or Worse: AI Is Transforming the Workplace]( CME SPOTLIGHT [Evaluating the Cause of Anemia: Diagnosis and Management of Myelodysplastic Syndromes]( [MEETING COVERAGE]( [COVID Tied to Changes in Brain Microstructure]( [RHEUMATOLOGY]( [Could Correcting Metabolic Dysfunction Treat Rheumatoid Arthritis?]( [ASCO READING ROOM]( [More Treatment-Guiding Interim PET-CT Scans Needed in Advanced Stage Hodgkin Lymphoma]( CME SPOTLIGHT [Advancing AML Care: A Targeted Approach]( # Weekly Survey [Is Mental Health History Needed for Licensure?]( The Americans With Disabilities Act prohibits discrimination against people with disabilities, yet state licensing applications often ask health workers about [mental health history]([VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-11-28&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

23/06/2024

Sent On

23/06/2024

Sent On

22/06/2024

Sent On

21/06/2024

Sent On

21/06/2024

Sent On

21/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.